Disease manifestations and X inactivation in heterozygous females with Fabry disease

被引:94
|
作者
Maier, Esther M.
Osterrieder, Stephanie
Whybra, Catharina
Ries, Markus
Gal, Andreas
Beck, Michael
Roscher, Adelbert A.
Muntau, Ania C. [1 ]
机构
[1] Univ Munich, Dr Von Hauner Childrens Hosp, Res Ctr, Dept Biochem Genet & Mol Biol, D-80337 Munich, Germany
[2] Johannes Gutenberg Univ Mainz, Dept Pediat, D-6500 Mainz, Germany
[3] NIH, Dev & Metab Neurol Branch, Bethesda, MD 20892 USA
[4] Univ Hamburg, Med Ctr Eppendorf, Hamburg, Germany
关键词
Fabry disease; lysosomal storage disorder; heterozygotes; X inactivation; HUMARA assay;
D O I
10.1080/08035320600618809
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aim: Fabry disease is an X-linked lysosomal storage disorder characterized by an accumulation of neutral glycosphingolipids in multiple organ systems caused by alpha-galactosidase A deficiency due to mutations in the GLA gene. The majority of heterozygous females show the characteristic signs and symptoms of the disease, and some of them are severely affected. The current hypothesis for the occurrence of disease manifestations in females is skewed X inactivation favouring the mutant GLA allele. Method: We analyzed the patterns of X inactivation in the leukocytes of 28 biochemically and genetically characterized symptomatic Fabry disease heterozygotes and their correlation with clinical and biochemical disease expression. Results: X inactivation patterns in symptomatic females who are heterozygous for Fabry disease did not differ from those of female controls of the same age (p = 0.669). Thirteen (46%) of the 28 females with Fabry disease showed random X inactivation, ten (36%) moderate skewing, and five (18%) highly skewed X inactivation. Segregation analysis was performed in the families of six females who had highly or moderately skewed X inactivation. In four of these females, skewing favoured the wild-type GLA allele and in the other two skewing favoured the mutant allele. Patterns of X inactivation or the extent of skewing were not related to the severity of clinical manifestations or to residual enzyme activity. Conclusion: In this study we provide evidence that heterozygous females with Fabry disease show random X inactivation. Our data do not support the hypothesis that the occurrence and severity of disease manifestations in the majority of Fabry heterozygotes are related to skewed X inactivation.
引用
收藏
页码:30 / 38
页数:9
相关论文
共 50 条
  • [1] Cardiac manifestations of Anderson-Fabry disease in heterozygous females
    Kampmann, C
    Baehner, F
    Whybra, C
    Martin, C
    Wiethoff, CM
    Ries, M
    Gal, A
    Beck, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (09) : 1668 - 1674
  • [2] X chromosome inactivation, α-galactosidase A activity and lyso-Gb3 in Danish heterozygous females with Fabry disease
    Effraimidis, Grigoris
    Duno, Morte
    Rasmussen, Ase Krogh
    Kistorp, Caroline
    Lavoie, Pamela
    Auray-Blais, Christiane
    Feldt-Ramsussen, Ulla
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S40 - S41
  • [3] Improving the detection of heterozygous females for Fabry disease
    Frabasil, Joaquin
    Durand, Consuelo
    Sokn, Silvia
    Gaggioli, Daniela
    Carozza, Patricia
    Beatriz Schenone, Andrea
    MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S47 - S48
  • [4] Pitfalls of X-chromosome inactivation testing in females with Fabry disease
    Reboun, Martin
    Sikora, Jakub
    Magner, Martin
    Wiederlechnerova, Helena
    Cerna, Alena
    Poupetova, Helena
    Storkanova, Gabriela
    Musalkova, Dita
    Dostalova, Gabriela
    Golan, Lubor
    Linhart, Ales
    Dvorakova, Lenka
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2022, 188 (07) : 1979 - 1989
  • [5] CARDIAC AND RENAL MANIFESTATIONS OF FABRY DISEASE IN A HETEROZYGOUS FEMALE
    Burka, Semenawit
    Flores, Eduardo D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 4440 - 4440
  • [6] Cardiovascular manifestations in females with Anderson-Fabry disease
    Sachdev, B
    Richfield, L
    Thaman, R
    Firoozi, S
    Gimeno, J
    Mehta, A
    Elliott, PM
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 214A - 214A
  • [7] X-inactivation in Fabry disease
    Elstein, Deborah
    Schachamorov, Ella
    Beeri, Rachel
    Altarescu, Gheona
    GENE, 2012, 505 (02) : 266 - 268
  • [8] Early cerebral manifestations in a young female with Fabry disease with skewed X-inactivation
    Bouwman, M. G.
    Rombach, S. M.
    Linthorst, G. E.
    Poorthuis, B. J. H. M.
    Deprez, R. H. Lekanne
    Aerts, J. M. F. G.
    Wijburg, F. A.
    CLINICAL GENETICS, 2011, 80 (05) : 500 - 502
  • [9] CARDIAC MANIFESTATIONS ARE UNDER-RECOGNIZED IN FEMALES WITH FABRY DISEASE
    Banikazemi, M.
    Kasmani, S.
    Atiga, W.
    Goker-Alpan, O.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2011, 34 : S189 - S189
  • [10] Kidney biopsy findings in heterozygous Fabry disease females with early nephropathy
    Carmen Valbuena
    Elísio Carvalho
    Manuela Bustorff
    Mariana Ganhão
    Sandra Relvas
    Rosete Nogueira
    Fátima Carneiro
    João Paulo Oliveira
    Virchows Archiv, 2009, 454 (6) : 721 - 722